Figure 4

 
  AT BE BG CY CZ DE DK EE ES FI FR GR HR HU IE IT LT LU LV MT NL PL PT RO SE SI SK UK   EU 28 WHO Europe   AL AM AZ BA BY CH GE IL IS KG KZ MD ME MK NO RS RU TJ TM TR UA UZ
Sarcoidosis 10.7 4.6   0.5 3.9   5.3   1.1 3.7     3.6     2.0 2.4 3.8 1.1 0.2   11.5 1.7     7.0 18.5 2.2   4.7 4.5             2.6   1.5 5.5           6.1              
Extrinsic allergic alveolitis 3.5 1.8     0.5   0.5   0.9 0.7     0.2     0.6 0.2 4.1 0.2 0.4   0.8 0.7     0.8 1.7 0.6   1.1 0.9             0.5   0.1 0.9           0.3              
Connective tissue disease 31.5 17.4   1.9 12.3   24.1   13.7 23.5     17.7     33.5 19.1 5.9 12.3 4.2   28.7 7.4     18.6 14.2 7.7   16.3 16.8             11.6   8.1 20.3           35.3              
Idiopathic fibrosing alveolitis and other ILD 13.9 3.3   1.1 11.5   24.9   3.3 13.5     7.8     3.8 3.0 7.2 4.8 12.9   15.0 2.3     10.4 23.6 8.4   9.5 8.9             6.3   3.3 7.5           8.3              
Figure 4 – Age-standardised annual hospital admissions (per 100 000) in the period 2005–2010 for the most important interstitial lung diseases (ILDs): sarcoidosis (International Classification of Disease (ICD)-10 code D86), chronic ILD (ICD-10 code J84; including idiopathic pulmonary fibrosis (IPF) and other forms of ILD), extrinsic allergic alveolitis (EAA) (ICD-10 code J67 ) and connective tissue disease (CTD) (ICD-10 code M32–M36). EU: European Union. Data from the World Health Organization (WHO) Hospital Morbidity Database, October 2011. Download Raw Data

See the entire Interstitial lung diseases Chapter